MidFirst Bank’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.87K Sell
21
-500
-96% -$61.4K ﹤0.01% 648
2026
Q1
$61.4K Sell
521
-1,302
-71% -$182K 0.01% 366
2025
Q4
$299K Buy
+1,823
New +$286K 0.02% 277

Other funds holding RGEN

MidFirst Bank's RGEN Position: Q2 2026 in Review

MidFirst Bank reduced its Repligen (RGEN) stake by 96% in Q2 2026, selling an estimated $61.4K and leaving 21 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #648.

MidFirst Bank first reported a position in RGEN in Q4 2025 and has held it in 3 quarters since. The position peaked at $299K in Q4 2025. 345 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • MidFirst Bank held 21 shares of Repligen worth $2.87K as of Q2 2026.
  • MidFirst Bank sold 500 Repligen shares in Q2 2026, an estimated $61.4K.
  • Repligen made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #648 holding.
  • MidFirst Bank first reported a position in Repligen in Q4 2025 and has held it in 3 quarters since.
  • MidFirst Bank's Repligen position peaked at $299K in Q4 2025.
  • 345 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.